Efficacy of red blood cell transfusion in the critically ill

Critical Care Clinics

Volumn 20, Issue 2, 2004, Pages 255-268

  Napolitano, Lena M ^a   Corwin, Howard L ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; DOBUTAMINE; HEMOGLOBIN; INTERLEUKIN 8; PROTEIN P50;

ACIDOSIS; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BLOOD RHEOLOGY; BLOOD VOLUME; CELL ADHESION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORRELATION COEFFICIENT; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; FOLLOW UP; HEART INDEX; HEART RATE; HEMODYNAMIC MONITORING; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; INTENSIVE CARE; LACTATE BLOOD LEVEL; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; META ANALYSIS; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; NEUTROPHIL; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PH MEASUREMENT; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SEPSIS; SPLANCHNIC BLOOD FLOW; STATISTICAL SIGNIFICANCE; TISSUE OXYGENATION; TONOMETER;

CLINICAL TRIALS; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; HUMANS; OXYGEN; RISK;

EID: 2342521318     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2003.12.002     Document Type: Review

References (50)

1. Hébert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., et al. A multi-center, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 340(6):1999;409-417
2. Vincent J.L., Baron J.F., Reinhart K., Gattinoni L., Thijs L., Webb A., et al. ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 288(12):2002;1499-1507
3. Corwin H.L., Gettinger A., Levy M.M., Fink M.P., Pearl R.G., Abraham E., et al. Anemia and blood transfusion in the critically ill: current clinical practice in the United States - The CRIT Study. Crit Care Med. 32:2004;39-52
4. Hébert P.C., Yetisir E., Martin C., Blajchman M.A., Wells G., Marshall J., et al. Transfusion requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 29(2):2001;227-234
5. Hébert P.C., Blajchman M.A., Cook D.J., Yetisir E., Wells G., Marshall J., et al. Transfusion requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Do blood transfusions improve outcomes related to mechanical ventilation? Chest. 119(6):2001;1850-1857
6. Blumberg N., Heal J.M. Effects of transfusion on immune function. Arch Pathol Lab Med. 118:1994;371-379
7. Landers D.F., Hill G.E., Wong K.C., Fox I.J. Blood transfusion-induced immunomodulation. Anesth Analg. 82:1996;187-204
8. Mickler T.A., Longnecker D.E. The immunosuppressive aspects of blood transfusion. J Intensive Care Med. 7:1992;176-188
9. Blajchman M.A. Immunomodulation and blood transfusion. Am J Ther. 9(5):2002;389-395
10. Hill G.E., Frawley W.H., Griffith K.E., Forestner J.E., Minei J.P. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 54(5):2003;908-914
11. Taylor R.W., Manganaro L., O'Brien J., Trottier S.J., Parkar N., Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 30:2002;2249-2254
12. Vamvakas E.C., Blajchman M.A. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction. Blood. 97:2001;1180-1195
13. Vamvakas E.C., Blajchman M.A. Universal WBC reduction: the case for and against. Transfusion. 41:2001;691-712
14. McAlister F.A., Clark H.D., Wells P.S., Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg. 85:1998;171-178
15. Hébert P.C., Fergusson D., Blajchman M.A., Wells G.A., Kmetic A., Coyle D., et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 289:2003;1941-1949
16. Dzik W.H., Anderson J.K., O'Neill E.M., Assmann S.F., Kalish L.A., Stowell C.P. A prospective, randomized clinical trial of universal WBC reduction. Transfusion. 42:2002;1114-1122
17. Shoemaker W.C., Appel P.L., Kram H.B. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest. 102(1):1992;208-215
18. Bishop M.H., Shoemaker W.C., Appel P.L., Meade P., Ordog G.J., Wasserberger J., et al. Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. J Trauma. 38(5):1995;780-787
19. Velmahos G.C., Demetriades D., Shoemaker W.C., Chan L.S., Tatevossian R., Wo C.C., et al. Endpoints of resuscitation of critically injured patients: normal or supranormal? A prospective randomized trial. Ann Surg. 232(3):2000;409-418
20. Kern J.W., Shoemaker W.C. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med. 30(8):2002;1686-1692
21. Alia I., Esteban A., Gordo F., Lorente J.A., Diaz C., Rodriguez J.A., et al. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest. 115(2):1999;453-461
22. Gattinoni L., Brazzi L., Pelosi P., Latini R., Tognoni G., Pesenti A., et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 333(16):1995;1025-1032
23. Heyland D.K., Cook D.J., King D., Kernerman P., Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. Crit Care Med. 24(3):1996;517-524
24. Shah D.M., Gottlieb M.E., Rahm R.L., Stratton H.H., Barie P.S., Paloski W.H., et al. Failure of red blood cell transfusion to increase oxygen transport or mixed venous PO2 in injured patients. J Trauma. 22(9):1982;741-746
25. Kahn R.C., Zaroulis C., Goetz W., Howland W.S. Hemodynamic oxygen transport and 2, 3-diphosphoglycerate changes after transfusion of patients in acute respiratory failure. Intensive Care Med. 12(1):1986;22-25
26. Gramm J., Smith S., Gamelli R.L., Dries D.J. Effect of transfusion on oxygen transport in critically ill patients. Shock. 5(3):1996;190-193
27. Mink R.B., Pollack M.M. Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med. 18(10):1990;1087-1091
28. Dietrich K.A., Conrad S.A., Hebert C.A., Levy G.L., Romero M.D. Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med. 18(9):1990;940-944
29. Babineau T.J., Dzik W.H., Borlase B.C., Baxter J.K., Bistrian B.R., Benotti P.N. Reevaluation of current transfusion practices in patients in surgical intensive care units. Am J Surg. 164(1):1992;22-25
30. Lorente J.A., Landin L., DePablo R., Renes E., Rodriguez-Diaz R., Liste D. Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med. 21(9):1993;1312-1318
31. Fernandes C.J. Jr., Akamine N., DeMarco F.V., DeSouza J.A., Lagudis S., Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care. 5(6):2001;362-367
32. Conrad S.A., Dietrich K.A., Hebert C.A., Romero M.D. Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock. 31(4):1990;419-429
33. Steffes C.P., Bender J.S., Levison M.A. Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med. 19(4):1991;512-517
34. Casutt M., Seifert B., Pasch T., Schmid E.R., Turina M.I., Dpahn D.R. Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med. 27(10):1999;2194-2200
35. Sehgal L.R., Zebala L.P., Takagi I., Curran R.D., Votapaka T.V., Caprini J.A. Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion. 41(5):2001;591-595
36. Silverman H.J., Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest. 102(1):1992;184-188
37. Ruokonen E., Takala J., Kari A. Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery. Crit Care Med. 21(9):1993;1304-1311
38. Marik P.E., Sibbald W.J. Effect of stored blood transfusion on oxygen delivery in patients with sepsis. JAMA. 269(23):1993;3024-3029
39. Fitzgerald R.D., Martin C.M., Dietz G.E., Doig G.S., Potter R.F., Sibbald W.J. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med. 25(5):1997;726-732
40. Berezina T.L., Zaets S.B., Morgan C., Spillert C.R., Kamiyama M., Spolarics Z., et al. Influence of storage on red blood cell rheological properties. J Surg Res. 102(1):2002;6-12
41. d'Almeida M.S., Jagger J., Duggan M., White M., Ellis C., Chin-Yee I.H. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion. Transfus Med. 10(4):2000;291-303
42. Hovav T., Yedgar S., Manny N., Barshtein G. Alteration of red cell aggregability and shape during blood storage. Transfusion. 39(3):1999;277-281
43. Nishiyama T., Hanaoka K. Hemolysis in stored red blood cell concentrates: modulation by haptoglobin or ulinastatin, a protease inhibitor. Crit Care Med. 29:2001;1979-1982
44. Schechter A.N., Gladwin M.T. Hemoglobin and the paracrine and endocrine functions of nitric oxide. Clinical implications of basic research. N Engl J Med. 348(15):2003;1483-1485
45. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 8(12):2002;1383-1389
46. Moore F.A., Moore E.E., Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 132(6):1997;620-624. discussion 624-5
47. Malone D.L., Dunne J., Tracy J.K., Putnam A.T., Scalea T.M., Napolitano L.M. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 54(5):2003;898-905. discussion 905-7
48. Zallen G., Offner P.J., Moore E.E., Blackwell J., Ciesla D.J., Gabriel J., et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 178:1999;570-572
49. Zallen G., Moore E.E., Ciesla D.J., Brown M., Biffl W.L., Silliman C.C. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock. 13(1):2000;29-33
50. Luk C.S., Gray-Statchuk L.A., Cepinkas G., Chin-Yee I.H. WBC reduction reduces storage-associated RBC adhesion to human vascular endothelial cells under conditions of continuous flow in vitro. Transfusion. 43(2):2003;151-156